Clinical characteristics and risk factors of protein-losing enteropathy: a retrospective study

• by Wen-Tao Tan, Zi-Teng Wang, Hui Su, Chun-Mei Guo, Wen-Bin Shen, Hong Liu

• May 8, 2026

First Preclinical Development Candidate for Nucleome Therapeutics

First-in-class monoclonal antibody agonist program for inflammation

• January 19, 2026

• 2 min

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

• by Kathryn Wighton

• January 27, 2026

• 3 min

AMA Backs Structured Vaccine Review

Medical societies and public health groups will collaborate on policy questions and evidence briefs for the 2026 to 2027 respiratory virus season.

• by Kathryn Wighton

• February 11, 2026

• 4 min